GLS and neoplasm: 6-diazo-5-oxo-L-norleucine competitively binds to the active site of glutamine and can form a covalent compound that irreversibly inhibits various glutamine metabolism-related enzymes such as GLS and GS, and produces analgesic, antiviral, and tumor inhibition effects (110, 111), alongside with strong side effects (111).